title: [Hyperparathyroidism and osteoporosis].
abstract: BACKGROUND
  In patients with primary hyperparathyroidism, a definite diagnosis is the first step in the management strategy and relies on appropriately selected and carefully interpreted laboratory tests. Parathyroid hormone assays are being increasingly performed as part of the routine evaluation of osteoporosis.
  
  
  BACKGROUND
  In this setting, laboratory tests are often consistent with primary hyperparathyroidism but should be interpreted with caution.
  
  
  CONCLUSIONS
  Bone mineral density measurements are useful for assessing the impact of primary hyperparathyroidism. The recommended bone mineral density cutoffs for selecting patients requiring parathyroidectomy were lowered in 2003, and the number of surgically treated patients has increased as a result. Parathyroidectomy remains the treatment of choice given the low mortality associated with this procedure and the absence of pharmacological alternatives suitable for long-term use.
authors.affiliation: Service de rhumatologie A, hôpital Cochin, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France. catherine.cormier@cch.ap-hop-paris.fr
authors.forename: C
authors.initials: C
authors.lastname: Cormier
authors.forename: J C
authors.initials: JC
authors.lastname: Souberbielle
authors.forename: A
authors.initials: A
authors.lastname: Kahan
mesh_terms: D015519:Bone Density; D003937:Diagnosis, Differential; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications* / Q000175:diagnosis*; D010024:Osteoporosis / Q000209:etiology*; D016105:Parathyroidectomy